首页> 外国专利> Bio-marker for non-invasive differential diagnosis of acute rejection in kidney transplanted patients and uses thereof

Bio-marker for non-invasive differential diagnosis of acute rejection in kidney transplanted patients and uses thereof

机译:用于肾脏移植患者急性排斥反应的非侵入性鉴别诊断的生物标志物及其用途

摘要

The present invention miR-4488, miR-4532, miR-146a-5p, miR-21-5p, miR-373-3p, miR-31-5p, miR-223-3p, miR-210- A marker composition for diagnosing an acute rejection of a kidney transplant comprising at least one miRNA selected from the group consisting of 3p and a combination thereof, a method for providing information necessary for diagnosing an acute rejection of a kidney transplant using the marker composition, the marker It relates to a diagnostic composition comprising an agent for measuring the expression level of, and a diagnostic kit comprising a quantitative device for the marker. MiR-4488, miR-4532, miR-146a-5p, miR-21-5p, miR-373-3p, miR-31-5p, miR-223-3p and miR-210-3p according to the present invention are kidney transplants Since acute rejection is present in the patient's urine at high levels, it can be used to conveniently diagnose acute rejection of kidney transplants in a non-invasive way.
机译:本发明的miR-4488,miR-4532,miR-146a-5p,miR-21-5p,miR-373-3p,miR-31-5p,miR-223-3p,miR-210-用于诊断的标志物组合物包含至少一种选自3p及其组合的miRNA的肾移植物的急性排斥反应,使用所述标记物组合物提供诊断肾移植物的急性排斥反应所必需的信息的方法,所述标记物诊断组合物,其包含用于测量其表达水平的试剂,和诊断试剂盒,其包含用于标记的定量装置。根据本发明的MiR-4488,miR-4532,miR-146a-5p,miR-21-5p,miR-373-3p,miR-31-5p,miR-223-3p和miR-210-3p是肾脏移植物由于患者尿液中存在急性排斥反应,因此可以以无创方式方便地诊断肾脏移植物的急性排斥反应。

著录项

  • 公开/公告号KR20200084435A

    专利类型

  • 公开/公告日2020-07-13

    原文格式PDF

  • 申请/专利权人 경희대학교 산학협력단;

    申请/专利号KR20180169490

  • 发明设计人 이상호;서정우;

    申请日2018-12-26

  • 分类号C12Q1/6883;G16B20;G16B25;

  • 国家 KR

  • 入库时间 2022-08-21 11:06:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号